Sonoma Pharmaceuticals, Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    (estimated) €18.31M +24.6% -€827.36K -58.5% -4.5% +0.091 pp N/A N/A
    (estimated) €14.70M +20.6% -€2.00M -32.3% -13.6% +0.11 pp N/A N/A
    €12.19M +12.2% -€2.95M -28.5% -24.2% +0.14 pp -€6.82K -99.7% -0.1% +0.19 pp
    €10.86M -4.0% -€4.12M -6.1% -38.0% +0.0084 pp -€2.03M -59.5% -18.7% +0.26 pp
    €11.32M +5.1% -€4.39M +1.3% -38.8% +0.015 pp -€5.02M +43.1% -44.3% -0.12 pp
    €10.77M -32.2% -€4.34M +10.2% -40.3% -0.16 pp -€3.51M +28.5% -32.6% -0.15 pp
    €15.89M -1.6% -€3.94M +56.7% -24.8% -0.092 pp -€2.73M -27.0% -17.2% +0.060 pp
    €16.15M -0.2% -€2.51M -75.0% -15.6% +0.47 pp -€3.74M -62.3% -23.2% +0.38 pp
    €16.18M +13.9% -€10.06M -17.7% -62.2% +0.24 pp -€9.91M -5.2% -61.2% +0.12 pp
    €14.21M +29.9% -€12.22M -254.5% -86.0% -1.6 pp -€10.45M +57.6% -73.6% -0.13 pp
    €10.94M -15.0% €7.91M -191.3% 72.3% +1.4 pp -€6.63M -7.5% -60.6% -0.049 pp
    €12.87M +8.9% -€8.67M +23.9% -67.4% -0.082 pp -€7.17M +28.2% -55.7% -0.084 pp
    €11.82M +1.4% -€7.00M -319.6% -59.2% -0.87 pp -€5.59M +49.5% -47.3% -0.15 pp
    €11.66M -11.5% €3.19M -168.8% 27.3% +0.62 pp -€3.74M -411.7% -32.1% -0.41 pp
    €13.18M +21.2% -€4.63M -25.9% -35.1% +0.22 pp €1.20M -138.1% 9.1% +0.38 pp
    €10.87M +30.7% -€6.25M -7.8% -57.5% +0.24 pp -€3.15M -13.1% -29.0% +0.15 pp
    €8.32M +32.5% -€6.78M -3.4% -81.5% +0.30 pp -€3.63M -34.5% -43.6% +0.45 pp
    €6.28M +36.7% -€7.02M -53.4% -111.8% +2.2 pp -€5.54M -60.5% -88.2% +2.2 pp
    €4.60M +40.5% -€15.06M -13.2% -327.7% +2.0 pp -€14.02M -2.3% -305.1% +1.3 pp
    €3.27M -15.6% -€17.35M +2.8% -530.4% -0.95 pp -€14.35M -2.2% -438.8% -0.60 pp
    €3.87M +75.8% -€16.87M -14.4% -435.5% +4.6 pp -€14.68M -14.1% -378.8% +4.0 pp
    €2.20M +90.6% -€19.70M +39.7% -893.9% +3.3 pp -€17.10M +60.5% -775.7% +1.5 pp
    €1.16M -€14.10M -1,219.0% -€10.65M -921.2%

    Notifications